The results demonstrated that 133La-labeled PSMA-I&T radiotracer demonstrated superior imaging performance, offering enhanced tumor delineation and spatial resolution compared to both 68Ga- and 89Zr-based imaging agents [129]. This evidence concerns the gene FOLH1 and neoplasm.